No Data
No Data
Express News | Septerna Inc - Expects Cash Position to Support Operations Into 2027
Express News | Septerna Inc - Decision Follows Severe Events of Elevated Bilirubin in Phase 1 Trial
Express News | Septerna Announces Discontinuation of SEP-786 Phase 1 Clinical Trial and Plans to Advance Next-Generation Oral Small Molecule Pth1R Agonist
Septerna Announces Discontinuation of SEP-786 Phase 1 Clinical Trial and Plans to Advance Next-Generation Oral Small Molecule PTH1R Agonist
Express News | Trading Halt: Halted at 7:55:00 A.m. ET - Trading Halt: Halt News Pending
Express News | Cantor Fitzgerald Reiterates Overweight on Septerna, Maintains $50 Price Target